Mortality within the trial period · preterm infants (< 37 weeks GA) at risk of chronic lung disease
Summary of findings table ‐ Salbutamol showed no clear difference in mortality within the trial period compared with placebo (low certainty).
1 finding from 1 review
Chronic lung disease · preterm infants (< 37 weeks GA) at risk of chronic lung disease
Summary of findings table ‐ Salbutamol showed no clear difference in chronic lung disease at 28 days compared with placebo (low certainty).
1 finding from 1 review
Hypokalaemia · preterm infants (< 37 weeks GA) at risk of chronic lung disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pneumothorax · preterm infants (< 37 weeks GA) at risk of chronic lung disease
1 finding from 1 review
Motor outcome in infancy (Bayley, Griffiths Locomotor) · preterm infants
1 finding from 1 review
Motor outcome at school age (Griffiths Locomotor, MABC) · preterm infants
2 findings from 1 review
Death or bronchopulmonary dysplasia · preterm infants with or at risk of respiratory distress syndrome
Surfactant administration via laryngeal mask airway (S‐LMA) showed no clear difference in death or bronchopulmonary dysplasia compared with surfactant administration via endotracheal tube (ETT) with the… (low certainty).
1 finding from 1 review
Pulmonary air leak · preterm infants with or at risk of respiratory distress syndrome
It is very uncertain whether surfactant administration via laryngeal mask airway (S‐LMA) changes pulmonary air leak, any (during first hospitalisation) Anytime to… compared with surfactant administration via endotracheal tube (ETT) with… (very low certainty).
1 finding from 1 review
Bronchopulmonary dysplasia · preterm infants with or at risk of respiratory distress syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intraventricular haemorrhage, Papile grade 3/4 · preterm infants with or at risk of respiratory distress syndrome
It is very uncertain whether surfactant administration via laryngeal mask airway (S‐LMA) changes intraventricular haemorrhage grade III and IV Anytime to discharge compared with surfactant administration via endotracheal tube (ETT) with… (very low certainty).
1 finding from 1 review
Mortality before hospital discharge · preterm infants with or at risk of respiratory distress syndrome
It is very uncertain whether surfactant administration via laryngeal mask airway (S‐LMA) changes death (all causes) during the first hospitalisation Anytime to… compared with surfactant administration via endotracheal tube (ETT) with… (very low certainty).
1 finding from 1 review
Neurosensory disability in survivors · preterm infants with or at risk of respiratory distress syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death or bronchopulmonary dysplasia · preterm infants with or at risk of respiratory distress syndrome
Surfactant administration via laryngeal mask airway (S‐LMA) showed no clear difference in death or bronchopulmonary dysplasia compared with no surfactant administration (low certainty).
1 finding from 1 review
Need for mechanical ventilation · preterm infants with or at risk of respiratory distress syndrome
Surfactant administration via laryngeal mask airway (S‐LMA) probably leads to lower mechanical ventilation at any time At any time to discharge compared with no surfactant administration (moderate certainty).
1 finding from 1 review
Pulmonary air leak · preterm infants with or at risk of respiratory distress syndrome
Surfactant administration via laryngeal mask airway (S‐LMA) showed no clear difference in pulmonary air leak, any (during first hospitalisation) Anytime to… compared with no surfactant administration (low certainty).
1 finding from 1 review
Bronchopulmonary dysplasia · preterm infants with or at risk of respiratory distress syndrome
Surfactant administration via laryngeal mask airway (S‐LMA) showed no clear difference in bronchopulmonary dysplasia (clinical definition) among survivors compared with no surfactant administration (low certainty).
1 finding from 1 review
Intraventricular haemorrhage, Papile grade 3/4 · preterm infants with or at risk of respiratory distress syndrome
1 finding from 1 review
Need for mechanical ventilation · preterm infants with or at risk of respiratory distress syndrome
Surfactant administration via laryngeal mask airway (S‐LMA) may leads to lower mechanical ventilation at any time Any time to discharge compared with surfactant administration via endotracheal tube (ETT) with the… (low certainty).
1 finding from 1 review
Mortality before hospital discharge · preterm infants with or at risk of respiratory distress syndrome
1 finding from 1 review
Neurosensory disability in survivors · preterm infants with or at risk of respiratory distress syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found